A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss by Anne G. M. Schilder, Stephan Wolpert, Shakeel Saeed, Leonie M. Middelink, Albert S. B. Edge, Helen Blackshaw, REGAIN Consortium, Kostas Pastiadis, Athanasios G. Bibas

Get full text